Provided by Tiger Trade Technology Pte. Ltd.

Yesterday's Top Gainers

729.29
-8.6927-1.18%
Number of Gainers:19
Number of Losers:31
Number of Flat:3
PE:- -
High:739.96
Open:738.04
Low:728.73
Close:737.98
Volume:70.10M
Turnover:1.00B
Market Cap:122.59B
Float Cap:76.60B

Loading ...

Uxin (UXIN.US) Q2 Trading Volume Jumps 89% Year-on-Year; Founder Dai Kun Launches Share Purchase Plan

Stock News
·
Sep 24

Uxin FY27 Q1 Net Loss Widens to RMB 178.4 Million; Revenue Rises 74.9% to RMB 1.15 Billion Year over Year

Reuters
·
Sep 24

Press Release: Uxin Reports Unaudited Financial Results for the Quarter Ended June 30, 2026

Dow Jones
·
Sep 24

Energy ETF Surges as Geopolitical Tensions Reshape Oil Market Dynamics

Stock News
·
Sep 24

UBS Reaffirms Their Buy Rating on Li Auto, Inc. Class A (L87)

TIPRANKS
·
Sep 24

EDU Holdings Cuts Share Count Through On-Market Buy-Back

TIPRANKS
·
Sep 24

GAC-Huawei brand Aistaland launches GX7, targeting extended-range SUV market

CnEVPost
·
Sep 24

PrimeEnergy Director H. Gifford Fong Acquires USD 21,170 in Common Shares

Reuters
·
Sep 24

EDU Holdings updates market on ongoing on‑market share buy‑back

TIPRANKS
·
Sep 24

Ethos Technologies Initiated at Buy on Strong Digital Momentum and Attractive 2027 EV/EBITDA Valuation

TIPRANKS
·
Sep 24

Vista Energy Sets Dates for Release of Q3 2026 Results and Investor Webcast

TIPRANKS
·
Sep 24

Regenxbio Says Sarepta to Pay $39 Million to Regenxbio Within 10 Days of Effective Date

Reuters
·
Sep 24

Regenxbio - Sarepta to Pay $39 Mln to Regenxbio Within 10 Days of Effective Date - SEC Filing

THOMSON REUTERS
·
Sep 24

Regenxbio - All Ongoing Patent Litigation Regarding Patents-in-Suit to be Terminated with Prejudice - SEC Filing

THOMSON REUTERS
·
Sep 24

Regenxbio - Agrees not to Sue Sarepta or Affiliates over Existing Elevidys or Aavrh74-Based Capsids - SEC Filing

THOMSON REUTERS
·
Sep 24

Regenxbio Inc: Co and Trustees of University of Pennsylvania Entered into Settlement Agreement with Sarepta Therapeutics Inc

THOMSON REUTERS
·
Sep 24

Regenxbio Settles Sarepta Patent Litigation over Elevidys for USD 39 Million

Reuters
·
Sep 24

Ethos price target raised to $38 from $32 at BofA

TIPRANKS
·
Sep 24

Volta Finance Posts Modest August Gain and Maintains Cautious CLO Stance

TIPRANKS
·
Sep 24

Volta Finance Limited Net Asset Value(s) as at 31 August 2026

GlobeNewswire
·
Sep 23